Los resultados de retatrutida, la tercera generación de los medicamentos GLP, muestran reducciones medias de 38,5 kg, equivalentes al 30,3% del peso corporal, en personas con obesidad mórbida Leer
A new anti-obesity drug breaks records by achieving a 30% weight loss after two years
Political Leaning Analysis
Score: 0.00 •
Center / Neutral
Left
Center
Right
Story Timeline
Thu 15:34 - El Mundo (ES)
A new anti-obesity drug breaks records by achieving a 30% weight loss after two years